当期純利益、新株予約権の行使、繰越利益剰余金他2件
- 【期間】
| 年度 | 当期純利益 | 新株予約権の行使 | 繰越利益剰余金 | 一般管理費及び当期製造費用に含まれる研究開発費 | 当期変動額合計 |
|---|
| 2007/03 | - | | - | | 79.9億 | | - | | - | |
| 2008/03 | 112億 | | 70百万 | | 66.4億 | -16.9% | - | | -145百万 | |
| 2009/03 | 82.5億 | -26.1% | - | | 45.8億 | -31.1% | - | | -9百万 | 赤縮 |
| 2010/03 | 29.6億 | -64.1% | 239百万 | +241.4% | 41.6億 | -9.2% | - | | -215百万 | 赤拡 |
| 2011/03 | 60.1億 | +102.8% | 0 | -100% | 36.8億 | -11.4% | - | | -2百万 | 赤縮 |
| 2012/03 | 74.1億 | +23.3% | - | | 62.2億 | +69% | - | | - | |
| 2013/03 | 82.3億 | +11.1% | - | | 85.8億 | +38% | 34億 | | 0 | +100% |
| 2014/03 | - | | - | | 80.6億 | -6.2% | 36.2億 | +6.3% | - | |
| 2015/03 | - | | - | | 87.2億 | +8.2% | 44.6億 | +23.3% | - | |
| 2016/03 | - | | - | | 55.3億 | -36.6% | 47.4億 | +6.3% | - | |
| 2017/03 | - | | - | | 64.2億 | +16.1% | 44億 | -7% | - | |
| 2018/03 | - | | - | | 55.7億 | -13.2% | - | | - | |
| 2019/03 | - | | - | | 29億 | -48% | - | | - | |
| 2020/03 | - | | - | | 16.8億 | -42.1% | - | | - | |
| 2021/03 | - | | - | | -41億 | 赤転 | - | | - | |
| 2022/03 | - | | - | | -41.9億 | 赤拡 | - | | - | |
| 2023/03 | - | | - | | 211億 | 黒転 | - | | - | |
